These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Oxalic Acid as a uremic toxin. Mydlík M; Derzsiová K J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441 [TBL] [Abstract][Full Text] [Related]
44. Results of 12 years' treatment of chronic renal failure by dialysis and transplantation. Price JD; Ashby KM; Reeve CE Can Med Assoc J; 1978 Feb; 118(3):263-6. PubMed ID: 343897 [TBL] [Abstract][Full Text] [Related]
45. Hemodialysis for oxaluric renal failure. Saxon A N Engl J Med; 1973 Mar; 288(10):526. PubMed ID: 4567492 [No Abstract] [Full Text] [Related]
46. [Activity of serum creatine phosphokinase in chronic renal failure treated by hemodialysis]. Desprez T; Degremont G; Arens G; Raviart B; Dequiedt P; Dracon M; Lelievre G; Tacquet A Lille Med; 1980; 25(6):257-9. PubMed ID: 7401894 [No Abstract] [Full Text] [Related]
47. [Use of chronic intermittent hemodialysis in the treatment of patients with chronic renal failure]. Smetisko A; Cecuk L; Thune S Lijec Vjesn; 1973 Jul; 95(7):400-3. PubMed ID: 4742197 [No Abstract] [Full Text] [Related]
48. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans. Montazerifar F; Hashemi M; Karajibani M; Dikshit M J Med Food; 2010 Dec; 13(6):1490-3. PubMed ID: 21091256 [TBL] [Abstract][Full Text] [Related]
49. [Changes in plasma levels of vitamin C during hemodialysis in patients with chronic uremia]. Dite P; Krch V; Groh J Tunis Med; 1968; 46(4):329-35. PubMed ID: 5713845 [No Abstract] [Full Text] [Related]
50. An overview of renal oxalosis. Lueck FM Nephrol Nurse; 1980; 2(3):13-4. PubMed ID: 6991966 [No Abstract] [Full Text] [Related]
51. Oxidative stress in haemodialysis. Loughrey CM; Young IS; Lightbody JH; McMaster D; McNamee PT; Trimble ER QJM; 1994 Nov; 87(11):679-83. PubMed ID: 7820542 [TBL] [Abstract][Full Text] [Related]
52. Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltration. Fehrman-Ekholm I; Lotsander A; Logan K; Dunge D; Odar-Cederlöf I; Kallner A Scand J Urol Nephrol; 2008; 42(1):74-80. PubMed ID: 18210337 [TBL] [Abstract][Full Text] [Related]
53. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism. Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074 [TBL] [Abstract][Full Text] [Related]
54. [Critical evaluation of the results of hemodialysis in the pediatric age]. Gusmano R; Gilli G; Perfumo F Minerva Nefrol; 1972; 19(2):60-9. PubMed ID: 4681262 [No Abstract] [Full Text] [Related]
55. [Changes in anti-oxidative homeostasis in hemodialysis patients]. Schmidtmann S; Popov I; Precht K; von Baehr R Z Urol Nephrol; 1989 Feb; 82(2):77-80. PubMed ID: 2728633 [TBL] [Abstract][Full Text] [Related]
56. [Vitamin K1 and C metabolism in uremia during hemodialysis]. Bakaev VV; Khomenko VF Urol Nefrol (Mosk); 1991; (1):40-3. PubMed ID: 1858205 [TBL] [Abstract][Full Text] [Related]
57. Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis. Berns JS; Mosenkis A Hemodial Int; 2005 Jan; 9(1):7-22. PubMed ID: 16191049 [TBL] [Abstract][Full Text] [Related]
58. [Levels of serum ascorbate and its metabolites in hemodialysis patients]. Hirano H; Tone Y; Otani H; Oya M; Kimura K; Saika Y; Fujii R; Mune M; Ichinose M; Yukawa S Nihon Jinzo Gakkai Shi; 2004 Jul; 46(5):426-33. PubMed ID: 15446598 [TBL] [Abstract][Full Text] [Related]
59. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Koenig JS; Fischer M; Bulant E; Tiran B; Elmadfa I; Druml W Wien Klin Wochenschr; 1997 Jan; 109(1):13-9. PubMed ID: 9037743 [TBL] [Abstract][Full Text] [Related]